ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 42 filers reported holding ALEXZA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.04 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $122,000 | +13.0% | 98,914 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $108,000 | -47.3% | 98,914 | 0.0% | 0.02% | -17.9% |
| Q1 2015 | $205,000 | +39.5% | 98,914 | 0.0% | 0.03% | -28.2% |
| Q4 2014 | $147,000 | -36.1% | 98,914 | 0.0% | 0.04% | -23.5% |
| Q3 2014 | $230,000 | -49.1% | 98,914 | 0.0% | 0.05% | -32.9% |
| Q2 2014 | $452,000 | +3.2% | 98,914 | 0.0% | 0.08% | +22.6% |
| Q1 2014 | $438,000 | -6.4% | 98,914 | 0.0% | 0.06% | -12.7% |
| Q4 2013 | $468,000 | -7.5% | 98,914 | 0.0% | 0.07% | -9.0% |
| Q3 2013 | $506,000 | +17.9% | 98,914 | 0.0% | 0.08% | -44.7% |
| Q2 2013 | $429,000 | – | 98,914 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS AUSTRIA GMBH | 1,693,833 | $3,947,000 | 80.83% |
| FORTALEZA ASSET MANAGEMENT INC/ | 126,095 | $294,000 | 0.14% |
| HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $230,000 | 0.05% |
| C WorldWide Group Holding A/S | 715,580 | $1,717,000 | 0.02% |
| Compagnie Lombard Odier SCmA | 187,600 | $437,000 | 0.02% |
| Lombard Odier & Cie (Bahamas) Ltd | 17,500 | $41,000 | 0.02% |
| Spark Investment Management LLC | 33,800 | $80,000 | 0.01% |
| Jefferies Group LLC | 536,800 | $1,251,000 | 0.01% |
| ROCKY MOUNTAIN ADVISERS, LLC | 350 | $1,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $117,000 | 0.00% |